Compare Dropbox Inc (DBX) vs Halozyme Therapeutics Inc. Common Stock (HALO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Dropbox Inc vs Halozyme Therapeutics Inc. Common Stock — how do they compare? Dropbox Inc trades at $34.36 (market cap $7.42B), while Halozyme Therapeutics Inc. Common Stock trades at $110.42 (market cap $12.58B). The key difference: Halozyme Therapeutics Inc. Common Stock is the larger of the two by market cap, and Halozyme Therapeutics Inc. Common Stock is trading nearer its 52-week high, Dropbox Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Dropbox Inc for 97 Days and Halozyme Therapeutics Inc. Common Stock for 1 Days on average.
| DBX | HALO | |
|---|---|---|
Market Cap | $7.42B | $12.58B |
Volume | 3,061,580 | 2,179,278 |
Sector | Technology | Health |
52-Week High | $37.74 | $115.22 |
52-Week Low | $22.06 | $61.63 |
Typical Hold Time | 97 Days | 1 Days |
Enterprise Value | $10.29B | $14.49B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Dropbox (DBX) trades at $34.36, up 3.87% with bullish technical signals and consistent earnings beats. The company maintains strong profitability with 79.72% gross margins and 20.16% net income margin, though revenue growth remains flat near $2.5B. Recent news highlights insider selling and a security breach affecting 5,000 accounts, while analyst sentiment is divided with a $26.83 consensus target below current price.
The outlook is mixed with solid fundamentals but concerning valuation and insider activity. Investment opportunity lies in sustained profitability and AI integration potential, while risks include stagnant growth, high debt levels, and negative shareholder equity. Wall Street remains cautious with equal buy/hold/sell distribution.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Dropbox Inc
Dropbox is a leading provider of cloud-storage and content collaboration tools with an emphasis on individuals and SMB. The company was founded in 2007 and was a pioneer in cloud storage and cross-platform file syncing. Utilizing inorganic and organic means, the firm has been working on diversifying its product mix and pivoting away from the cloud-storage space.
Read more on DBX →About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →
